首页|期刊导航|癌症生物学与医学(英文版)|Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer:a prospective,multicenter,non-interventional study(FLOURISH)

Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer:a prospective,multicenter,non-interventional study(FLOURISH)OA

Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer:a prospective,multicenter,non-interventional study(FLOURISH)

Lisha Shen;Ligang Xing;Ke Xie;Jiuwei Cui;Lin Mu;Chao Cao;Liren Ding;Peifeng Chen;Jun Liang;Yongmin Ding;Liqin Lu;Dongqing Lv;Jiliang Zhang;Xinmin Yu;Li Chen;Jing Zheng;Jianya Zhou;Jianying Zhou;Ke-Jing Tang;Jun Zhao;Dan Zhu;Yanqiu Zhao;Ke Wang;Yan Wang;Zhigang Cai

Department of Respiratory Disease,Thoracic Disease Center,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310058,ChinaShandong Cancer Hospital and Institute,Shandong First Medical University,Jinan 250014,ChinaSichuan Provincial People's Hospital,Chengdu 610072,ChinaThe First Hospital of Jilin University,Changchun 130021,ChinaHeping Hospital Affiliated to Changzhi Medical College,Changzhi 046000,ChinaThe First Affiliated Hospital of Ningbo University,Ningbo 315010,ChinaThe Second Affiliated Hospital(Binjiang Campus),School of Medicine,Zhejiang University,Hangzhou 310022,ChinaZhuji People's Hospital,Zhuji 311800,ChinaPeking University International Hospital,Beijing 102206,ChinaShengzhou People's Hospital,Shengzhou 312400,ChinaZhejiang Provincial People's Hospital,Hangzhou 310014,ChinaDepartment of Respiratory Disease,Affiliated Taizhou Hospital of Zhejiang Province of Wenzhou Medical University,Taizhou 318000,ChinaChengdu Seventh People's Hospital(Affiliated Cancer Hospital of Chengdu Medical College),Chengdu 610072,ChinaZhejiang Cancer Hospital,Hangzhou 310022,ChinaThe First Affiliated Hospital of Nanchang University,Nanchang 330006,ChinaDepartment of Respiratory Disease,Thoracic Disease Center,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310058,ChinaDepartment of Respiratory Disease,Thoracic Disease Center,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310058,ChinaDepartment of Respiratory Disease,Thoracic Disease Center,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310058,ChinaDepartment of Respiratory Disease,The First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,ChinaChangzhi People's Hospital Affiliated to Changzhi Medical College,Changzhi 046000,ChinaJinhua Municipal Central Hospital,Jinhua 321000,ChinaThe Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital,Zhengzhou 450008,ChinaWest China Hospital of Sichuan University,Chengdu 610041,ChinaTumor Hospital Affiliated to Harbin Medical University,Harbin 150081,ChinaThe Second Hospital of Hebei Medical University,Shijiazhuang 050000,China

Osimertinibepidermal growth factor receptornon-small cell lung cancerreal-worldco-mutations

Osimertinibepidermal growth factor receptornon-small cell lung cancerreal-worldco-mutations

《癌症生物学与医学(英文版)》 2026 (8)

1156-1166,中插7-中插10,15

This work was supported by a grant from AstraZeneca China.

10.20892/j.issn.2095-3941.2025.0566

评论